Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 56124

AbstractMaterial and MethodsResultsDiscussionConclusionAcknowledgementReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Original article / research
Year : 2021 | Month : July | Volume : 15 | Issue : 7 | Page : BC09 - BC14 Full Version

Distribution of Apolipoprotein A1 Polymorphism (G-75A and C+83T) in Patients with Diabetic Foot Ulcers- A Parallel Group Hospital Based Observational Study


Published: July 1, 2021 | DOI: https://doi.org/10.7860/JCDR/2021/48456.15160
Rachita Nanda, Suprava Patel, Preetam Wasnik, Radhakrishna Ramchandani, Debajyoti Mohanty, Eli Mohapatra

1. Additional Professor, Department of Biochemistry, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India. 2. Associate Professor, Department of Biochemistry, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India. 3. Associate Professor, Department of Medicine, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India. 4. Associate Professor, Department of Surgery, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India. 5. Additional Professor, Department of Surgery, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India. 6. Professor and Head, Department of Biochemistry, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.

Correspondence Address :
Rachita Nanda,
Gate No. 5, College Building, All India Institute of Medical Sciences,
Raipur-492099, Chhattisgarh, India.
E-mail: dr.rachitananda@gmail.com

Abstract

Introduction: Diabetic Foot Ulcer (DFU), a serious complications of diabetes mellitus is a result of persistent low grade infection. The Apolipoprotein A1 (ApoA1) has an anti-inflammatory role and therefore can influence the chronic inflammation associated with the DFU. Polymorphisms of ApoA1gene have been implicated as determinants of plasma High-Density Lipoprotein cholesterol (HDL-C) and Apo A1 levels. However, the influence of ApoA1 polymorphism on susceptibility to DFU has not been studied.

Aim: To study the distribution of ApoA1 polymorphism (G-75A and C+83T) and association between the polymorphism and the risk of DFU in patients with Type 2 Diabetes Mellitus (T2DM) so that timely detection and prevention of DFU can be done.

Materials and Methods: This was a hospital based observational study on 80 patients of DFU, 80 diabetes mellitus without ulcers and 75 normal controls. ApoA1 polymorphism (G-75A and C+83T) was detected by Real Time Polymerase Chain Reaction (RT-PCR) technique and plasma ApoA1 by immunoturbidimetric assay using blood collected in EDTA. Data was analysed using IBM® Statistical Package for Social Sciences (SPSS) 21.0 software. A p<0.05 was considered as statistically significant.

Results: The GA and CC were the most predominant genotype in all the groups. HDL and ApoA1 were significantly lower in GG (p=0.009, p=0.03) and CT (p=0.03, p=0.002) compared to GA and CC. The APOA1-75A allele and +83C allele were associated with raised levels of HDL and ApoA1 in T2DM and DFU (p<0.05).

Conclusion: The two polymorphism G-75A and C+83T were found to be equally distributed across the study populations. These polymorphisms were associated with serum levels of ApoA1 and HDL in the DFU patients.

Keywords

Allele, Anti-inflammatory, Dyslipidaemia, Genotype, High density lipoprotein

The DFU is one of the most severe complications of Diabetes Mellitus (DM), with complications affecting over 30% diabetic patients, and DFU being the leading cause of nontraumatic amputation among adults in the working age group (1). In countries like India, where there is wide spread diffusion of diabetes at an alarming rate, the burden of DFU is also exponentially increasing the economic load on the patient. According to the International Diabetes Federation, the average global prevalence of diabetic foot complications is 6.4% with the prevalence being higher in males and among people with T2DM (2). The prevalence of diabetes is varied ranging from 5.3% in central India to 13.6% in Northern India (1).

To contain the huge cost and challenge, detection and effective management of DFU at early stages is essential. Diabetes mellitus with its multitude of factors like microvascular and macrovascular complications, peripheral neuropathy, duration of diabetes, control of plasma glucose and trauma serve as risk factors for DFU (3). The multifactorial process involved in DFU calls for a multidisciplinary approach for treatment where along with control of infection, debridement, adequate perfusion, newer wound dressings like growth factors and tissues from bioengineering have been included (4). The pathogenesis of DFU is unclear and the association of various genes related to inflammatory can play an important role in the development of DFU (5),(6). The early onset of ulcers is due to the influence of environmental factors, and their modifying effects on the early disclosure of gene factors. Therefore, genetic testing could potentially be used to identify patients more vulnerable to early development of DFU.

Type II Diabetes mellitus is associated with dyslipidaemia characterised by high triglycerides level and low High Density Lipoprotein (HDL) (7). Evidence is evolving that ApoA1, the major lipoprotein of HDL has anti-inflammatory, anti-infective and endotoxin neutralising effects. It inhibits monocyte inflammatory function in peripheral blood mononuclear cells (8). A persistent low grade inflammation is associated with the pathogenesis of DM, which lowers the HDL and further the ApoA1 level, however, all patients of DM do not develop DFU. At the start, the wound in DFU passes through acute inflammatory phase followed by a phase of remodeling and healing. The chronicity of inflammation with infection may result in the DFU to progress to amputation. The chronic inflammation that accompanies DFUs suppresses the focused acute inflammatory response to injury that is needed for normal wound healing which results in impaired leukocyte function and aberrant expression and activity of inflammatory cytokines (9). Two Single Nucleotide Polymorphisms (SNPs) of ApoA1 gene {-75 G/A (rs 1799837) and +83 C/T (rs 5069)} of ApoA1 gene have been identified to affect HDL and ApoA1 by altering their levels (10),(11),(12). It has also been found that ApoA1 -75 G/A and +83 C/T genotypes are associated with DM but with inconclusive findings (13). The relation of ApoA1 and the genetic association of -75 G/A and +83 C/T polymorphisms has not been studied in DFU.

Therefore, the aim of the present study was to find the distribution of ApoA1 polymorphism (-75 G/A and +83 C/T) and association between the two genetic variants with susceptibility to DFU and correlation with plasma levels of HDL and ApoA1, so that timely detection and prevention of DFU can be done.

Material and Methods

It was a hospital based observational study. Patients were recruited from the Outpatient Clinics of Medicine and Surgery of the Institute over a period of 12 months from January to December 2019 at AIIMS, Chhattisgarh, India. A total of 235 adults which included 80 DFU, 80 T2DM without DFU and 75 age matched healthy controls were enrolled for this parallel group. Institutional Ethics Committee approval (Ethical clearance obtained vide IEC Proposal No. AIIMSRPR/IEC/2018/128) was obtained before initiation of research work and written informed consent was obtained from all participants.

Sample size calculation: Sample size for frequency in a population was calculated at 97% Confidence Interval (CI), 90% power, ratio of controls to cases being one, and proportion of cases with exposure being 13.6, the sample size was 74. All patients were enrolled after evaluation by the clinical co-investigators and detailed history was recorded with help of a case proforma.

Inclusion criteria: Patients of DFU who were defined as diabetic patients with ‘ulceration, infection, or destruction of deep tissues located in the lower limb below the ankles were included in the study (14).

Exclusion criteria: Patients with ulcers on both feet, or with acute inflammation, hepatic, cardiac or renal failure, varicose veins, malignancy and psychiatric disorders were excluded from the study.

Sample Collection

Venous blood (5 mL) was collected from all participants under aseptic conditions in Ethylenediaminetetraacetic Acid (EDTA) vacutainers for polymorphism studies as well for measurement of ApoA1. Genomic Deoxyribonucleic Acid (DNA) was extracted using commercially available kit Qiagen kit (QIAEN Inc., Valencis, CA, USA) as per manufacturer’s instructions and the extracted DNA was stored at -20°C for analysis of polymorphisms. Plasma collected was also stored at -20°C for determination of ApoA1.

Detection of Polymorphisms

The polymorphisms of ApoA1, G-75A (rs1799837) and C+83T (rs5069), along with allelic discrimination were analysed using pre-validated TaqMan based human Single Nucleotide Polymorphisms (SNPs) genotyping RT-PCR assay (Helini Biomolecules, Chennai, India). The assay has two unlabelled primers, forward and reverse primers, along with Fluorescein Amidites (FAM) and Hexachloro-Fluorescein (HEX) dual-labeled probes to detect both alleles (Supplementary Table-1). The PCR reaction set up was composed of Taq enzyme activation for 15 minutes at 95°C, followed by denaturation at 95°C for 20 seconds, annealing at 58°C for 20 seconds and extension at 72°C for 20 seconds as per manufacturer’s instructions. Forty such cycles of denaturation, annealing and extension completed the reaction.

Biochemical Investigations

Detailed investigation reports with regard to plasma glucose, Haemoglobin A1c (HbA1c), lipid profile and renal function test were obtained from the patient records. The level of ApoA1 was determined in Beckman AU680 analyser by immunoturbidimetric immunoassay method at 340 nm using commercially available kits from Randox Laboratories Ltd., (UK). The assay was carried out according to the protocol described in the kit manual. The assay range for ApoA1 is 5.78-234 mg/dL, intra assay and inter assay CV% is 3.08 and 2.04 respectively. The minimum detectable level was determined as 5.78 mg/dL.

Statistical Analysis

Data was checked for normality distribution after which continuous variables were reported as means with Standard Deviations (SD). For qualitative data, proportions were summarised. The genotype frequencies of the two polymorphisms were tested for Hardy-Weinberg Equilibrium (HWE) using Goodness of fit, Chi-square test. Genotype and allele frequency between controls and cases were analysed using Chi-square test and confidence interval. Comparison of data in three groups was done using analysis of variance (ANOVA) and post-hoc Tukey’s test. Logistic regression analysis was performed to estimate the Odds Ratio (OR) and 95% confidence interval for strength association. Data was analysed using IBM® SPSS 21 software. p<0.05 was considered as statistically significant.

Results

Characteristics of study groups: The demographic details of the study population is depicted in (Table/Fig 1) showed no significant difference in age between control, patients of T2DM and those of DFU. A higher number of males were observed in DFU group compared to T2DM and control groups (p=0.03). The authors assume that exposure to the different risks like trauma and plantar pressure was more in men as they had more outdoor activities than females. Obesity is a well known risk factor for diabetes and its complications and this study depicted that the DFU group was significantly heavier and had lesser height in comparison to the healthy controls (p=0.03) and with a higher BMI when compared to T2DM and healthy controls, p=0.002, p<0.001 respectively. Longer periods of the diabetic state was observed in DFU group than T2DM (p=0.005).

Clinical complications and biochemical analysis: The clinical complications and biochemical analysis are presented in (Table/Fig 2). The duration of diabetes and associated complications like neuropathy, retinopathy, dyslipidaemia were the clinical risk factors along with family history of diabetes for developing foot ulcers. While considering the biochemical analysis, markers of glycaemic control [Fasting Plasma Glucose (FPG), Post Prandial Plasma Glucose (PPPG), HbA1c], renal function tests and lipid biomarkers were significantly altered in DFU group (p<0.001) justifying the clinical risk factors. These results show that poor plasma glucose control and dyslipidaemia could be linked to delayed wound healing.

ApoA1 polymorphisms, lipids and Diabetic Foot Ulcers (DFU): The RT-PCR curves of APoA1 polymorphisms rs1799837 and rs5069 are presented in (Supplementary Figure-2a,b). The frequency of Apo A1 genotypes for G-75A and C+83T polymorphism for HWE in study population and the expected and observed frequency for these Apo A1 variants are depicted in (Supplementary Table-3). The distribution of C+83T genotype as well as G-75A did not follow HWE. The authors assume that this deviation from HWE is less probable due to genotyping errors as RT-PCR technique was used instead of Restriction Fragment Length Polymorphism (RFLP). This departure from equilibrium could be due to its proximity to an allele affecting a phenotype on which the sample is ascertained, or by chance. It is likely to be a selection bias introduced in the present study population because it is a hospital based study and due to the predefined disease profile of patients.

Analysis of genotypic and allelic frequency distribution of Apo A1 polymorphism, G-75A C+83T, in (Table/Fig 3) showed that amongst the genetic parameters, the most predominant genotype at G-75A was GA with highest frequency in T2DM followed by DFU and controls. The GA genotype was significantly more in T2DM than in DFU from controls (p=0.03). There was one individual with AA genotype in T2DM group. At the C+83T site the predominant genotype was wild type CC with highest frequency in T2DM followed by DFU and controls. Frequency of both the CC and CT genotypes in the patient groups were not significantly different from that in the control group. The mutant genotype GA was predominant whereas the wild genotype CC was more prevalent among the study groups however the authors speculate that ApoA1 gene polymorphisms rs1799837 and rs5069 had no obvious association with DFU susceptibility in the population of Chhattisgarh.

In (Table/Fig 4), while assessing the effect of the genotype on lipid profile the HDL and ApoA1 were significantly higher in GA (p=0.009, p=0.03) and CC (p=0.03, p=0.002) genotype compared to GG and CT genotypes, respectively.

The lipid profile was further compared in the different genotypes in the three study groups (Table/Fig 5), (Table/Fig 6). The HDL and ApoA1 were significantly lower in GG genotype compared with the GA genotype in T2DM and DFU (Table/Fig 5). A similar analysis at +83bp suggested that heterozygosity at the point had lower levels of HDL and ApoA1 and that the CC genotype showed highest level of protection in all subjects (Table/Fig 6). This indicates that the GA and CC genotypes elevate HDL and ApoA1 concentration.

Discussion

The pathogenesis of DFU is complex because it is caused by multiple factors like genetic and environmental which also influence the healing of ulcer. Apart from trauma, infection, neuropathies, altered functioning of white blood cells and regenerating tissue along with bacterial infection contribute to delayed healing (15). HDL and its apoprotein, ApoA1 have cytoprotective and wound healing effects, which is vital in diabetes mellitus as there is a milieu of altered endothelial function and poor wound healing, thus this lipoprotein, can play a role in healing of DFU (16). Experiments in mice model have shown reconstituted HDL to improved wound healing containing human ApoA1 protein (17). Similarly, lower levels of HDL has also been associated with lower extremity amputation and wound related death in patients with DFU (18). This was the first study where the ApoA1 polymorphism is being studied in DFUs. Since, the polymorphisms G-75A and C+83T are involved in HDL and ApoA1 levels (11), the study aimed to investigate the pattern of this polymorphism and its association with DFUs.

The authors assessed the impact of ApoA1 polymorphism on the risk of the development of DFU. After literature search the authors did not find any published study that had evaluated DFU with respect to ApoA1 polymorphism. The slightly higher age group and male preponderance of DFU observed in the present study is reported by others as well which is probably due to the chronicity of the disease (1),(19). Compared to T2DM patients, the DFU population had a greater duration of diabetes and higher incidence of neuropathy, retinopathy, dyslipidaemia and risk factors like family history of diabetes. There was no statistical difference between the frequency of hypertension or obesity in T2DM and DFU groups. Similar such complications and risk factors were observed by other researchers (20),(21). The renal function tests of urea, creatinine and uric acid were higher in DFU groups, although nephropathy was not observed in T2DM or DFU cases. The lipid profile biomarkers were significantly elevated in DFU patients except for HDL and ApoA1 which were significantly lower. The presence of low HDL and ApoA1 in DFU may indicate inhibition of its anti-inflammatory role which it does by modulating innate immunity as well as adaptive immunity (22).

In diabetes the dyslipidaemia is primarily characterised by increased triglyceride level and lowered HDL level. However, the association of ApoA1 polymorphism with serum HDL and ApoA1 level remains controversial (10),(11),(23). Polymorphism of the ApoA1 gene was studied in two sites G-75A and C+83T in the first intron. The genotype GA was found more frequently in controls, T2DM as well as DFU patients than the GG phenotype. The presence of genotype GA was not significantly associated with developing DFU (OR=1.7, CI- 0.923-3.325, p=0.08), dampened by the wide confidence interval. Of the two alleles the G allele was more frequent and was present in similar frequencies in the three groups than A allele. Certain studies of ApoA1 polymorphism involving G-75A, similar findings were obtained (11),(24). In contrast other authors observed significant difference in allelic frequency (10),(25). The authors found a positive association of A allele on HDL and ApoA1 level similar to that of Yangchun Z et al., and Saha N et al., (26),(27). In contrast, Bora K et al., observed no such effect (11). Individuals with GA genotype had a significant higher value of HDL and ApoA1, which was observed across T2DM and DFU groups also indicating the protective nature. This could be one of the reasons why the authors could not get any history of myocardial infarction, even though the population was of middle age group. Also, there was no previous history of DFU in these patients as high ApoA1 and HDL have anti-inflammatory role. One of the reasons for the elevated ApoA1 and the HDL level is that presence of A allele increases the transcriptional efficiency of the promoter. Further, it decreases the binding affinity of a 90kD factor to the -75bp position and reduces the repression of ApoA1 gene transcription (10).

The genotype CC was found more frequently in controls, T2DM as well as DFU patients than CT genotype, with no difference in the CC genotype amongst the groups. Of the two alleles the C allele was more frequent and it was present in similar frequencies across the three groups than the T allele, indicating no relation with the DFU group. The C allele has been shown to be higher amongst controls in few studies (12),(25),(28),(29), although it has been refuted by few researchers (10),(30). In CC genotype, there was a higher value of HDL and ApoA1 levels in the three groups as compared to the CT genotype. The CT group had a significantly lower HDL and ApoA1 levels in the entire study population across diabetes and DFU groups. Liao BH et al., had found no association between +83C/T and lipids (31). Further, the presence of CT with OR=0.7 did not confer susceptibility towards developing DFU (CI- 0.424-1.401, p=0.393). The C+83T polymorphism located in the first intron of ApoA1 is a part of Cp nucleotide expressed differently in nonexpressing and expressing tissues like liver. Wang XL et al., and Shemer R et al., had mentioned that C+83T transition results in demethylation of the gene resulting in increased ApoA1 expression and thus high HDL level (30),(32). However, Bora K et al., in his study found no difference in ApoA1 levels in CC and CT genotypes (11). No TT genotype was observed in the three groups.

The GA and CC were the predominant genotypes equally present in all the three groups of DFU, T2DM and controls. The G and C alleles were the frequent in all the three groups with no difference in the frequency among the three groups. This could be because these polymorphisms at the two sites could be in linkage disequilibrium with each other or with nearby gene. The GA and CC genotype were associated with significantly high levels of HDL and ApoA1 levels in all the three groups. This effect could be as a result of the disease process or various other hormonal, metabolic or environmental factors that could have modulated the genotype effect on HDL and ApoA1 for the development of a complex complication like DFU.

Limitation(s)

The limitations of this study was that diabetes is a polygenic disease, where there are a multitude combination of genes and environmental factors that can influence the outcome. It is difficult to pin point on a single polymorphism, but going by the anti-inflammatory role of HDL and Apo A1 this preliminary study may be helpful. Secondly, the population of T2DM and DFU were on medications and that could influence the lipid profile although the regression analysis took into consideration these parameters during analysis. Also, the populations in different literature quoted are from different ethnic population in comparison to this study. The short term and the observational nature of the study may also limit the findings and statistical power of the study. Since, all patients were recruited from a single hospital, the scope of the present result may be limited.

Conclusion

The GA genotype which was more prevalent appeared protective due to higher levels of HDL and ApoA1 whereas the CT genotype individuals had a lower HDL and ApoA1 levels. It is recommended that further progressive research to focus on gene-gene interaction and gene-environment interactions and its relationship with the genotypic variations of ApoA1 gene in DFU patients. Therefore, well designed studies using whole genome sequencing is necessary to divulge extensive level of variation and heterogeneity between individuals can be undertaken with adequate sample size to eliminate bias in candidate gene selection is necessary to carry the work further ahead.

Acknowledgement

All India Institute of Medical Sciences, Raipur, India for Intramural grant support.

References

1.
Seth A, Attri AK, Kataria H, Kochhar S, Seth SA, Gautam N. Clinical profile and outcome in patients of diabetic foot infection. Int J App Basic Med Res. 2019;9:14-19. [crossref] [PubMed]
2.
International Diabetes Federation. IDF Diabetes Atlas, 9th edn. Brussels, Belgium: 2019. Available at: https://www.diabetesatlas.org.
3.
Younis BB, Shahid A, Arshad R, Khurshid S, Ahmad M, Yousaf H. Frequency of foot ulcers in people with type 2 diabetes, presenting to specialist diabetes clinic at a Tertiary Care Hospital, Lahore, Pakistan. BMC Endocr Disord. 2018;18:53. https://doi.org/10.1186/s12902-018-0282-y. [crossref] [PubMed]
4.
Perez-Favila A, Martinez-Fierro ML, Rodriguez-Lazalde JG, Cid-Baez MA, Zamudio-Osuna MJ, Martinez-Blanco MR, et al. Current therapeutic strategies in diabetic foot ulcers. Medicina. 2019;55(11):714. [crossref] [PubMed]
5.
Vaseghi H, Pornour M, Djavid GE, Rigi G, Ganji SM, Novin L. Association of the gene expression variation of tumor necrosis factor-α and expressions changes of dopamine receptor genes in progression of diabetic severe foot ulcers. Iran J Basic Med Sci. 2017;20(11):1213-19. Doi: 10.22038/IJBMS.2017.9475. [crossref]
6.
Dhamodharan U, Viswanathan V, Krishnamoorthy E, Rajaram R, Aravindhan V. Genetic association of IL-6 and TNF-α and SDF-1 polymorphisms wit serum cytokine level in diabetic foot ulcers. Gene. 2015;565(1):62-67. https://doi.org/10.1016/j.gene.2015.03.063. [crossref] [PubMed]
7.
Schofield JD, Liu Y, Rao-Balakrishna P, Malik RA, Soran H. Diabetes dyslipidemia. Diabetes Thera 2016;7(2):203-19. Doi: 10.1007/s13300-016-0167-x. [crossref] [PubMed]
8.
Mangaraj M, Nanda R, Panda S. ApolipoproteinA-I: A molecule of diverse function. Ind J Clin Biochem. 2016;31(3):253-59. [crossref] [PubMed]
9.
Widgerow AD. Bioengineering and the diabetic foot ulcer. Wound Healing Southern Africa 2012;5(2):64-67.
10.
Dawar R, Gurtoo A, Singh R. Apolipoprotein A1 gene polymorphism (G-75A and C+83T) in patients with myocardial infarction: A pilot study in a north India population. Am J Clin Pathol. 2010;134:249-55. [crossref] [PubMed]
11.
Bora K, Pathak MS, Borah P, Hussain MI, Das D. Single nucleotide polymorphisms of APOA1 gene and their relationship with serum apolipoprotein A-I concentrations in the native population. Meta Gene. 2016;7:20-27. Doi: 10.1016/j.mgene.2015.10.005. [crossref] [PubMed]
12.
Chhabra S, Narang R, Lakshmy R, Das N. APOA1-75G to A substitution associated with severe forms of CAD, lower levels of HDL and apoA-I among northern Indians. Dis Markers. 2005;21(4):169-74. Doi: 10.1155/2005/195078. [crossref] [PubMed]
13.
Khodaeian M, Enayati S, Tabatabaei-Malazy O, Amoli MM. Association between genetic variants and diabetes mellitus in Iranian populations: A systematic review of observational studies. Journal of Diabetes Research. 2015;2015:585917. Doi: 10.1155/2015/585917. [crossref] [PubMed]
14.
Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, et al. Toronto Diabetic Neuropathy Expert Group. Diabetic neuropathies: Update on definitions, diagnosis criteria, estimation of severity, and treatments. Diabetes Care. 2010;33:2285-93. Doi: 10.2337/dc10-1303. [crossref] [PubMed]
15.
Jeffcoate WJ, Vileikyte L, Boyko EJ, Armstrong DG, Boulton AJM. Current challenges and opportunities in the prevention and management of diabetic foot. Diabetes Care. 2018;41:645-52. Doi: 10.2337/dc17-1836. [crossref] [PubMed]
16.
Simha V, Kudva YC. HDL cholesterol story is dead: Long live HDL. Diabetes. 2016;65:2826-28. Doi: 10.2337/dbi16-0039. [crossref] [PubMed]
17.
Tan JTM, Prosser HCG, Dunn LL, Vanags LZ, Ridiandries A, Tsatralis T, et al. High-density lipoproteins rescue diabetes-impaired angiogenesis via scavenger receptor class B type I. Diabetes. 2016;65:3091-103. [crossref] [PubMed]
18.
Ikura K, Hanai K, Shinjyo T, Uchigata Y. HDL cholesterol as a predictor for the incidence of lower extremity amputation and wound-related death in patients with diabetic foot. Atherosclerosis 2015;239(2):465-69. Doi: 10.1016/j.atherosclerosis.2015.02.006. [crossref] [PubMed]
19.
Tiwari S, Pratyush DD, Dwivedi A, Gupta SK, Rai M, Singh SK. Microbiological and clinical characteristics of diabetic foot infections in Northern India. J Infect Dev Ctries. 2012;6:329-32. [crossref] [PubMed]
20.
Vibha SP, Kulkarni MM, Ballala ABK, Kamath A, Maiya GA. Community based study to assess the prevalence of diabetic foot syndrome and associated risk factors among people with diabetes mellitus. BMC Endocrine disorders. 2018;18:43. https://doi.org/10.1186/s12902-018-0270-2. [crossref] [PubMed]
21.
Beata MR, Agnieszka SK, Szymański K, Nehring P, Szatkowski P, Bartkowiak-Wieczorek, et al. Role of the rs2274907 allelic variant of the ITLN1 gene in patients with diabetic foot. Pol Arch Intern Med. 2017;127(5):319-27. Doi: 10.20452/pamw.4008. [crossref]
22.
Vuilleumier N, Dayer JM, von Eckardstein A, Roux-Lombard P. Pro-or anti-inflammatory role of apolipoprotein A-1 in high-density lipoproteins? Swiss Med Wkly. 2013;143:w1378. Doi: 10.4414/smw.2013.13781. [crossref] [PubMed]
23.
Hsu LC, Lee TH. Apolipoprotein A1 rs5070 A/G polymorphism with stroke subtypes. Journ Chinese Med Assoc 2017;80:360-65. Doi: 10.1016/j.jcma.2017.01.002. [crossref] [PubMed]
24.
Biswas S, Ghosal PK, Halder B, Ganguly K, DasBiswas A, Mandal N. Apolipoprotein AI/B/E gene polymorphism and their plasma levels in patients with coronary artery disease in a tertiary care-centre of Eastern India. Indian Heart J. 2013;65:658-65. [crossref] [PubMed]
25.
Khan T, Qazi F, Rasool S, Rashid S, Akhtar Q, Masood A, et al. Genetic variants at the ApoA1 gene in association with coronary artery disease. Int J Sci. 2012;5(1):33-42.
26.
Yangchun Z, Dayi H, Xinchun Y. Relationship among apolipoprotein A1 gene polymorphism, lipid levels and coronary atherosclerosis disease. Chin Med J (Engl). 2003;116:665-68.
27.
Saha N, Tay JSH, Low PS. Guanidine to adenine (G/A) substitution in the promoter region of the apolipoprotein A1 gene is associated with elevated serum apoliporotein A1 levels in Chinese nonsmokers. Genet Epidemiol. 1994;11:255-64. [crossref] [PubMed]
28.
de França, Alves JGB, Hutz MH. APOA1/C3/A4 gene cluster variability and lipid levels in Brazilian children. Braz J Med Biol Res. 2005;38(4):535-41. [crossref] [PubMed]
29.
Padmaja MR, Adithan KC. Association of polymorphisms in apolipoprotein A1 and apolipoprotein B genes with lipid profile in Tamilian population. Indian Heart J. 2009;61:51-54.
30.
Wang XL, Badenhop R, Humphrey KE, Wilcken DE. New MspI polymorphism at +83 bp of the human apolipoprotein A1gene: Association with increased circulating high density lipoprotein cholesterol levels. Genet Epidemiol. 1996;13:01-10. 3.0.CO;2-D>[crossref]
31.
Liao BH, Cheng KQ, Dong SH, Liu HD, Xu ZL. Effect of apolipoprotein genetic polymorphisms on lipid profiles and the risk of coronary artery disease. Diagnostic Pathology. 2015;10:102. Doi: 10.1186/s13000-015-0328-7. [crossref] [PubMed]
32.
Shemer R, Walsh A, Eisenberg S, Breslow JL, Razin A. Tissue-specific methylation patterns and expression of the human apolipoprotein AI gene. J Biol Chem. 1990;265(2):1010-15. [crossref]

DOI and Others

10.7860/JCDR/2021/48456.15160

Date of Submission: Jan 09, 2021
Date of Peer Review: Mar 06, 2021
Date of Acceptance: Apr 05, 2021
Date of Publishing: Jul 01, 2021

AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was Ethics Committee Approval obtained for this study? Yes
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. NA

PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Jan 11, 2021
• Manual Googling: Mar 23, 2021
• iThenticate Software: Apr 24, 2021 (19%)

ETYMOLOGY: Author Origin

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com